Enrollment of older adults on oncology trials: An FDA perspective

被引:40
作者
Singh, Harpreet [1 ]
Beaver, Julia A. [1 ]
Kim, Geoffrey [1 ]
Pazdur, Richard [1 ]
机构
[1] US FDA, Off Hematol & Oncol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
D O I
10.1016/j.jgo.2016.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:149 / 150
页数:2
相关论文
共 7 条
[1]  
[Anonymous], 2012, Guidance for Industry E7 Studies in Support of Special Populations: Geriatrics Questions and Answers
[2]  
[Anonymous], 1994, GUIDANCE IND STUDIES
[3]  
[Anonymous], 2001, GUIDANCE IND CONTENT
[4]  
[Anonymous], 1989, GUIDELINE STUDY DRUG
[5]  
Hinshaw Trevor, 2013, P T, V38, P535
[6]   Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation [J].
Smith, Benjamin D. ;
Smith, Grace L. ;
Hurria, Arti ;
Hortobagyi, Gabriel N. ;
Buchholz, Thomas A. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) :2758-2765
[7]   Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration [J].
Talarico, L ;
Chen, G ;
Pazdur, R .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4626-4631